Eyetech Pharmaceuticals
About:
Eyetech Pharmaceuticals is a biopharmaceutical company that specializes in novel therapeutics to treat diseases of the eye.
Website: http://www.eyetk.com/
Top Investors: MPM Capital, JPMorgan Partners, Alta Partners, Merrill Lynch, BB Biotech Ventures
Description:
Eyetech Pharmaceuticals is a biopharmaceutical company that specializes in novel therapeutics to treat diseases of the eye. The company conducted research and development into wet age-related macular degeneration diseases, which was seen as a breakthrough in the field. Valeant Pharmaceuticals International acquired Eyetech for US$22 million in 2012.
$109M
New York, New York, United States
1997-01-01
Anthony P. Adamis, David Guyer, Marty Glick, Samir Patel
251-500
2001-08-08
Delisted
© 2025 bioDAO.ai